Delisting riskPopularity #4,321
ZeroStack (ZSTK)
Stakes 0G tokens and distributes pharmaceuticals through its German Phatebo business.
$3.95
After hours−0.16 (−3.89%)
At close$4.11(−4.86%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17 | 18 | 18 | 16 | 12 | 13 | 12 | 15 | 10 | 9 | 7 | 14 |
| Cost of revenue | 12 | 14 | 14 | 13 | 10 | 11 | 9 | 12 | 9 | 12 | 8 | 15 |
| Gross profit | 5 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 0 | −3 | −1 | −1 |
| 5 | 11 | 6 | 7 | 7 | 9 | 4 | 5 | 4 | 2 | 1 | 1 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 5 | 6 | 4 | 5 | 5 | 8 | 4 | 5 | 3 | 2 | 1 | 1 | |
| Selling & marketing | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 |
| General & administrative | 3 | 5 | 3 | 4 | 4 | 6 | 3 | 4 | 2 | 2 | 0 | 0 |
| Other expenses | 1 | 5 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 |
| Operating income | −1 | −7 | −2 | −4 | −4 | −6 | −1 | −3 | −3 | −4 | −1 | −2 |
| 1 | 0 | −1 | 1 | 0 | 0 | 0 | 0 | 0 | −106 | −35 | −22 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | −1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 1 | −8 | −3 | −3 | −4 | −6 | −1 | −2 | −4 | −110 | −37 | −24 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 1 | −7 | −3 | −3 | −4 | −6 | −1 | −2 | −4 | −110 | −37 | −25 |
| Discontinued operations | 0 | −2 | 0 | 0 | 0 | 0 | 0 | 0 | −3 | 0 | 0 | 0 |
| Net income | 1 | −10 | −3 | −3 | −4 | −6 | −1 | −2 | −7 | −110 | −37 | −25 |
| EPS, basic | $0.09 | −$36.16 | −$14.76 | −$8.35 | −$11.03 | −$16.88 | −$1.54 | −$4.27 | −$9.05 | −$105.07 | −$3.68 | −$2.47 |
| EPS, diluted | $0.08 | −$36.16 | −$14.76 | −$8.35 | −$11.03 | −$16.88 | −$1.54 | −$4.27 | −$9.05 | −$105.07 | −$3.68 | −$2.47 |
| Weighted average shares, basic | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 10 | 10 |
| Weighted average shares, diluted | 8 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 10 | 10 |
| EBITDA | 1 | −7 | −3 | −3 | −4 | −6 | 0 | −2 | −3 | — | −1 | −2 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | 0 | 0 |
| EBIT | 1 | −7 | −3 | −3 | −4 | −6 | −1 | −2 | −4 | −4 | −1 | −2 |
